Pear Therapeutics, Inc.

Thimble Point Acquisition Corp. (Nasdaq: THMA) is a healthcare-focused blank check company that completed its initial public offering in 2021. Sponsored by Thimble Point LLC, the vehicle was formed to pursue acquisition targets in digital health and life sciences. THMA entered a definitive business combination agreement with Pear Therapeutics, Inc., a prescription digital therapeutics company focused on behavioral health conditions including substance use disorders, with the transaction closing in December 2022. The August 2021 10-Q filing reflects the SPAC during its pre-announcement search phase, prior to any target being publicly identified. For complete filing histories, deal timelines, and sponsor data across the SPAC universe, create a free account at SpacDesk.